FDA guidelines and animal models for osteoporosis
- 1 October 1995
- Vol. 17 (4) , S125-S133
- https://doi.org/10.1016/8756-3282(95)00285-l
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.Journal of Clinical Investigation, 1993
- Maintaining restored bone with bisphosphonate in the ovariectomized rat skeleton: Dynamic histomorphometry of changes in bone massBone, 1993
- On the rat model of human osteopenias and osteoporosesBone and Mineral, 1992
- The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboonsJournal of Bone and Mineral Research, 1992
- The ovariectomized rat model of postmenopausal bone lossBone and Mineral, 1991